Publications

EU Reports | Network Evolution and Visualization
Innovation and Corporate Growth | Health Economics

Gambardella A, Orsenigo L., Pammolli F.:
Global Competitiveness in Pharmaceuticals - A European Perspective,
Directorate Enterprise, European Commission (2001)

Allansdottir A., Bonaccorsi A., Gambardella A., Mariani M., Orsenigo L., Pammolli F., Riccaboni M.:
Innovation and Competitiveness in European Biotechnology,
Directorate Enterprise, European Commission (2002)

Pammolli F., Riccaboni M., Oglialoro C., Magazzini L., Baio G., Salerno N.:
Medical Devices Competitiveness and Impact on Public Health Expenditure,
Directorate Enterprise, European Commission (2005)

^ Top | EU Reports | Network Evolution and Visualization
Innovation and Corporate Growth | Health Economics

Moody J., D. McFarland, S. Bender-deMoll (2005):
Dynamic Network Visualization,
American Journal of Sociology, 110/4, 1206-1241
get the pdf from the SoNIA website

Pammolli F., L. Orsenigo, M. Riccaboni (2001):
Technological Change and Network Dynamics: Lessons from the Pharmaceutical Industry,
Research Policy, 30(3), 485-508

Owen-Smith J., M. Riccaboni, F. Pammolli, WW Powell (2002):
A Comparison of US and European University-Industry Relations in the Life Sciences,
Management Science, 48(1), 24-43

Riccaboni M., F. Pammolli (2002):
On Firm Growth in Networks,
Research Policy, 31(8-9), 1405-1416

Pammolli F., M. Riccaboni (2003):
Technological Paradigms and the Evolution of Networks,
Ch.2 in Saviotti PP (ed) Applied Evolutionary Economics: New Empirical Methods and Simulation Techniques, Edward Elgar, Cheltenham

Riccaboni M., F. Pammolli (2003):
Technological Regimes and the Evolution of Networks of Innovators: Lessons from Biotechnology and Pharmaceuticals,
International Journal of Technology Management, 25(3/4), 334-350

Pammolli F., M. Riccaboni (2002):
Technological Regimes and the Growth of Networks: An Empirical Analysis,
Small Business Economics, 19(3), 205-215

Pammolli F., M. Riccaboni (2002):
Technological Competencies in Networks of Innovators,
Ch.6 in J. Cantwell, A. Gambardella, O. Grandstrand (eds), Economics and Management of Technological Diversification, Routledge, London

Pammolli F., M. Riccaboni, J. Owen-Smith, W.W. Powell (2002):
Europe and the United States: The Power of Networks,
Biofutur, 222, 26-29

Pammolli F., L. Orsenigo, A. Bonaccorsi, G. Turchetti, M. Riccaboni (1997):
The Evolution of Knowledge and the Dynamics of an Industry Network,
Journal of Management and Governance, 1(2), 147-175

Riccaboni M. (2003):
Cambiamento Tecnologico e Reti di Imprese,
Franco Angeli, Milano, Italy

^ Top | EU Reports | Network Evolution and Visualization
Innovation and Corporate Growth | Health Economics

D. Fu, F. Pammolli, S. V. Buldyrev, M. Riccaboni, K. Matia, K. Yamasaki, and H. E. Stanley:
The growth of business firms: Theoretical framework and empirical evidence,
Proc. Natl. Acad. Sci. 102, 18801--18806 (2005)

Bottazzi G., Dosi G., Lippi M., Pammolli F., Riccaboni M.:
Innovation and Corporate Growth in the Evolution of the Drug Industry,
International Journal of Industrial Organization, vol. 19(7), pp. 1161-1187 (2001)

G. De Fabritiis, F. Pammolli, Riccaboni M.:
On Size and Growth of Business Firms,
Physica A, 324 No. 1-2, pp. 38-44 (2003)

K. Matia, D. Fu, S. V. Buldyrev, F. Pammolli, M. Riccaboni, and H. E. Stanley:
Statistical Properties of Business Firm Structure and Growth,
Europhys. Lett. 67, 493-503 (2004)

^ Top | EU Reports | Network Evolution and Visualization
Innovation and Corporate Growth | Health Economics

G. Baio, J. P. Jansen (2005):
Introduction to Decision-Theoretic Networks for Pharmacoeconomics (PDF, 191 Kb),
submitted to Value in Health

G. Baio, F. Pammolli, V. Baldo, R. Trivello (2005):
Object Oriented Influence Diagram for Cost Effectiveness Analysis of Influenza Vaccination in Italian Elderly Population (PDF, 197 Kb),
submitted to Expert Review of Pharmacoeconomics and Outcome Research

L. Magazzini, F. Pammolli, and M. Riccaboni (2004):
Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure,
European Journal of Health Economics, 5 (2), 175-182

Russo P, Capone A, Attanasio E, Baio G, Di Martino M, Degli Esposti L. (2003):
Pharmacoutilization and Costs of Osteoarthritis: changes induced by the introduction of a cyclooxygenase-2 inhibitor into clinical practice,
Rheumatology 42, 879-887

Baio G., L. Degli Esposti, E. Degli Esposti, F. Pammolli, S. Saragoni, P. Russo (2003):
Bayesian Cost Effectiveness Analysis Based on Antihypertensive Treatment Continuity,
Expert Review of Pharmacoeconomics and Outcome Research, 3 (3), 89-98

F. Pammolli, L. Magazzini, L.Orsenigo (2002):
The intensity of competition after patent expiry in pharmaceuticals: a cross-country analysis,
Revue d'Economie Industrielle, 99

Degli Esposti L., Baio G., Valpiani G., Buda S., Sturani A., Degli Esposti E. (2002):
Cost Allocation in Antihypertensive Drug Therapies,
Expert Review of Pharmacoeconomics & Outcomes Research, 2(5), 89-95

^ Top | EU Reports | Network Evolution and Visualization
Innovation and Corporate Growth | Health Economics